Venoteks Compression Stockings: Black, Class 2, 1 Pair

$252
In stock — ready to ship

Title: VENOTEKS Compression Stockings - Black, Compression Class 2, 1 Pair

Product Description:

Experience superior comfort and support with VENOTEKS Class 2 compression stockings. Designed for individuals experiencing leg discomfort due to various venous conditions, these stockings offer targeted compression to alleviate symptoms and promote healthy circulation.

Indications:

  • Significant leg swelling (not resolving overnight)
  • Varicose veins with associated pain, heaviness, night cramps, and restless legs syndrome
  • Chronic venous insufficiency (CVI)
  • Prevention of venous thrombosis (deep vein thrombosis - DVT)
  • Acute thrombophlebitis
  • Preventing recurrence of venous trophic ulcers
  • Venous disorders during pregnancy
  • Post-sclerotherapy and venous surgery recovery

Benefits:

  • Precise Compression: Circular knitting with a core yarn ensures a precise compression gradient, with maximum pressure at the ankle, conforming to Class 2 compression standards.
  • Superior Elasticity & Durability: High-quality medical-grade LYCRA® ensures exceptional elasticity and maintains compression properties for at least 6 months with daily wear.
  • Easy to Wear: The LYCRA® content makes these stockings easy to put on.
  • Soft & Comfortable: 40% microfiber content provides a soft, skin-friendly feel.
  • Secure Fit: A wide, comfortable knit waistband ensures a secure and comfortable fit.
  • Safety Certified: OEKO-TEX certified, guaranteeing the absence of harmful substances.

Composition:

65% Polyamide (with microfiber), 35% LYCRA®

Registered Medical Name:

Compression Stockings, Art. 2P391

Registration Certificate:

FSZ 2012/13480

Keywords:

Compression stockings, compression socks, Class 2 compression, venous insufficiency, varicose veins, leg swelling, DVT prevention, thrombophlebitis, LYCRA®, microfiber, OEKO-TEX certified, medical grade stockings, VENOTEKS, 2P391, leg pain relief, restless legs syndrome, pregnancy, post-sclerotherapy, chronic venous disease, CVI treatment.